ArticleClinical and experimental immunology2021

Effectiveness of low-dose intravenous immunoglobulin therapy in minor primary antibody deficiencies: A 2-year real-life experience.

Emanuele Vivarelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.